Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP712507.RATvTIHpMdgRsCr8Yzfo9_IDmS93eys7mwjsmSFDfS51A130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP712507.RATvTIHpMdgRsCr8Yzfo9_IDmS93eys7mwjsmSFDfS51A130_assertion type Assertion NP712507.RATvTIHpMdgRsCr8Yzfo9_IDmS93eys7mwjsmSFDfS51A130_head.
- NP712507.RATvTIHpMdgRsCr8Yzfo9_IDmS93eys7mwjsmSFDfS51A130_assertion wasGeneratedBy ECO_0000203 NP712507.RATvTIHpMdgRsCr8Yzfo9_IDmS93eys7mwjsmSFDfS51A130_provenance.
- NP712507.RATvTIHpMdgRsCr8Yzfo9_IDmS93eys7mwjsmSFDfS51A130_assertion wasDerivedFrom befree-20140225 NP712507.RATvTIHpMdgRsCr8Yzfo9_IDmS93eys7mwjsmSFDfS51A130_provenance.
- NP712507.RATvTIHpMdgRsCr8Yzfo9_IDmS93eys7mwjsmSFDfS51A130_assertion SIO_000772 10363563 NP712507.RATvTIHpMdgRsCr8Yzfo9_IDmS93eys7mwjsmSFDfS51A130_provenance.
- NP712507.RATvTIHpMdgRsCr8Yzfo9_IDmS93eys7mwjsmSFDfS51A130_assertion evidence source_evidence_literature NP712507.RATvTIHpMdgRsCr8Yzfo9_IDmS93eys7mwjsmSFDfS51A130_provenance.
- NP712507.RATvTIHpMdgRsCr8Yzfo9_IDmS93eys7mwjsmSFDfS51A130_assertion description "[Nitric oxide synthase III (NOS III), an endothelial form, was detected in 25% of ovarian and 33% of endometrial cancers, while no expression was detected in uterocervical cancers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP712507.RATvTIHpMdgRsCr8Yzfo9_IDmS93eys7mwjsmSFDfS51A130_provenance.